Finding cheap shares is never as easy as contrarians would have you believe, says Tom Bulford. Here, he explains why the real money is in buying small-caps with the potential to be huge.
Biotechnology has opened up a whole raft of exciting opportunities for investors, says Tom Bulford. Here, he looks at one stock that could be about to transform what you...
Britain's culture of entitlement has put the country on the road to ruin, says Tom Bulford. It's time politicians realised they must be cruel to be kind.
This year will see a resurgence in China's stock market, says one Chinese businessman. Tom Bulford explains why intrepid penny share investors could be well placed to profit.
On a recent trip to China, Tom Bulford was struck by the prosperity of the place. And as far as he can see, nothing looks like derailing its mighty...
Tom Bulford recites a typical year-end speech from the chairman of a small-cap company, with a translation of what he really means.
This year has been a good one for penny share investors, says Tom Bulford. And 2013 is shaping up to be just as promising.
The biotech sector has been getting investors in America excited, says Tom Bulford. And with plenty of new drugs in the pipeline, 2013 promises to be a bumper year.
A medical breakthrough can utterly transform the fortunes of a small-cap biotech over night, says Tom Bulford - as this exciting penny share is finding out.
With the mining sector having failed to deliver time and again, it's little wonder investors have turned their backs. But that could be a costly mistake, says Tom Bulford....